Press Releases 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 CMS Establishes Unique J-Code for BELRAPZO™ (Bendamustine 500mL Hydrochloride Injection) 4/22/19 Eagle Pharmaceuticals, Inc. Expands Licensing Agreement for BENDEKA™ with Teva Pharmaceuticals International GmbH 4/15/19 Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2018 Results 2/28/19 Eagle Pharmaceuticals to Discuss Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019 2/19/19 Eagle Pharmaceuticals, Inc. to Present at 37th Annual J.P. Morgan Healthcare Conference 1/2/19 Pagination First page Previous page Page 1 Page 2 Current page 3
